We read with interest the article published by Salah et al. (1) In light of the current available knowledge, and to better understand the prognostic effect of renal kinetics in ADHF patients, we identify 3 scenarios that must be considered: In contrast, clinical awareness should be adopted in cases of coexistence of WRF with clinical deterioration, persistent hypotension, oliguria, and either no significant decrease or even increase of natriuretic peptides. Thus, and relative to the Salah et al.
mirroring hemoconcentration, a condition associated to decongestion and clinical improvement (3).
In light of the current available knowledge, and to better understand the prognostic effect of renal kinetics in ADHF patients, we identify 3 scenarios that must be considered: In contrast, clinical awareness should be adopted in cases of coexistence of WRF with clinical deterioration, persistent hypotension, oliguria, and either no significant decrease or even increase of natriuretic peptides. Thus, and relative to the Salah et al.
(1) data, we speculate a potential differential prognostic effect of WRF across NT-proBNP changes. 
